Title:
DOSAGES FOR TREATMENT WITH ANTI-ErbB2 ANTIBODIES
Document Type and Number:
Japanese Patent JP2020063266
Kind Code:
A
Abstract:
To provide a method for treatment of disorders characterized by overexpression of ErbB2.SOLUTION: A method for treatment of a human patient suspected of or diagnosed as having a disorder characterized by overexpression of the ErbB2 receptor comprises administering an effective amount of an anti-ErbB2 antibody to the human patient, and comprises: administering to the patient an initial dose of at least approximately 5 mg/kg of the anti-ErbB2 antibody; and administering to the patient a plurality of subsequent doses of the antibody in an amount that is approximately equal to or less than the initial dose.SELECTED DRAWING: Figure 1
Inventors:
BAUGHMAN SHARON ANN
SHAK STEVEN
SHAK STEVEN
Application Number:
JP2019217932A
Publication Date:
April 23, 2020
Filing Date:
December 02, 2019
Export Citation:
Assignee:
GENENTECH INC
International Classes:
A61K39/395; A61K31/337; A61K31/704; A61K45/00; A61P15/00; A61P35/00; A61P35/02; A61P43/00; C07K16/32; A61K38/12
Attorney, Agent or Firm:
Sonoda/Kobayashi Patent Business Corporation